The status of naloxone in community pharmacies across Canada.

So, Randy; Al Hamarneh, Yazid; Barnes, Mark; Beazely, Michael A; Boivin, Michael; Laroche, Julie; Patel, Harsit; Sihota, Aaron; Smith, Tim; Tsuyuki, Ross T

So, Randy; Al Hamarneh, Yazid; Barnes, Mark; Beazely, Michael A; Boivin, Michael; Laroche, Julie; Patel, Harsit; Sihota, Aaron; Smith, Tim; Tsuyuki, Ross T.

Afiliação

So R; University of Alberta (So, Al Harmarneh, Tsuyuki), Edmonton, Alberta.
Al Hamarneh Y; RespectRx (Barnes), Ottawa, ON.
Barnes M; Faculty of Pharmacy (Beazely), University of Waterloo, Waterloo, ON.
Beazely MA; CommPharm Consulting (Boivin), Barrie, ON.
Boivin M; Familiprix (Laroche), St-Lin Laurentides, QC.
Laroche J; Hamilton General Hospital (Patel), Hamilton Health Sciences Center, Hamilton, ON.
Patel H; University of British Columbia (Sihota), Vancouver, BC.
Sihota A; Pharmacists Manitoba (Smith), Winnipeg, MB.
Smith T; Northwest Territories Pharmacy Association (Smith), Yellowknife, NT.
Tsuyuki RT; University of Alberta (So, Al Harmarneh, Tsuyuki), Edmonton, Alberta.

Can Pharm J (Ott) ; 153(6): 352-356, 2020.

Article em En | MEDLINE | ID: mdl-33282025

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article